Shares of Ora Banda Mining (OBM.AX) slumped 8.6% to A$1.17 on Tuesday, extending a punishing five-session slide from A$1.41 as a textbook bearish chart pattern and stubbornly high production costs converge to rattle investors in this Western Australian gold miner.
The Chart Is Flashing a Warning Signal That Could Mean Another 40% Drop Technical analysts have identified a Head and Shoulders pattern — a formation that often signals a trend reversal — with a critical "neckline" at roughly A$1.05. A decisive break below that level projects downside toward A$0.65, which would nearly halve the stock from here. The 200-day moving average near A$1.28 was a key support level , and today's price has blown through it. The next technical support sits at A$1.15 — barely a breath away from the current price.
Costs Have Ballooned Far Beyond What Management Promised
Ora Banda originally guided FY26 all-in sustaining costs (AISC) — the total expense to produce each ounce of gold — at A$2,800–A$2,900 per ounce. Reality diverged sharply. The company revised that guidance to A$3,250–A$3,350 per ounce , and the March quarter AISC spiked to A$3,612 per ounce, reflecting higher volumes processed through costly third-party facilities. That is roughly 25% above the original target. While gold prices above US$3,000/oz still provide a margin cushion, the cost blowout erodes the earnings story investors bought into.
A Record Cash Pile Buys Time, but the Expansion Is a High-Stakes Bet
The March 2026 quarter delivered a record cash balance of A$231.7 million and free cash flow of A$76.3 million. Yet the board has signed off on a transformational A$375 million processing expansion aimed at tripling milling capacity to slash unit costs. The company's history of plant reliability issues and the sheer scale of the capital commitment relative to its market capitalisation mean execution risk remains front and centre.
Analysts Still See Value — But the Market Disagrees Right Now
Five analysts cover the stock with Buy or Strong Buy ratings and a mean target of A$1.95, implying roughly 47% upside. That gap between Wall Street optimism and market reality underscores investor anxiety: if costs don't normalize and the chart breaks A$1.05, the growth narrative could unravel before the new plant ever pours its first bar.